Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate
Revista Brasileira de Ginecologia e Obstetrícia · 2025
DOI: 10.61622/rbgo/2025rbgo9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Brasileira de Ginecologia e Obstetrícia, 2025. Verfasst von Giani Silvana Schwengber Cezimbra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de São Paulo Escola Paulista de Medicina Department of Obstetrics São PauloSP Brazil Department of Obstetrics, Escola Paulista d…. Hauptthemen laut MEDLINE: Medroxyprogesterone Acetate, Mental Disorders, Patient Satisfaction, Contraceptive Agents, Female. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To evaluate the continuation rate, satisfaction, and reasons for discontinuation of depot medroxyprogesterone acetate (DMPA) in adolescents treated in a mental health service.
Methods
Prospective cohort study conducted in a reference unit for the care of adolescents with mental disorders (MDs) and intellectual disabilities (IDs). All patients received a gynecological consultation and an educational group on contraceptive methods. Sociodemographic data on age, education and gynecological data (menarche, coitarche, regularity of menstrual cycles and presence of symptoms) were collected. Follow-up was quarterly for 12 months, during which symptoms, desire to continue, and satisfaction with the use of the quarterly injectable were assessed.
Results
Eight hundred and sixty-two sexually active adolescents were supported, 532 adolescents chose to use the quarterly injectable, and 69 of these agreed to participate in the study. The mean age of users was 15.5 years (SD=0.91). After 12 months of follow-up, 34 (49.3%) of the 69 adolescents continued to use the method and 36 (52.3%) were satisfied. Among the 33 (47.8%) who discontinued use, the most common reasons were irregular bleeding and weight gain.
Conclusions
Adolescents with intellectual disabilities and/or other mental disorders showed a significant rate of continuation and satisfaction with the use of the depot medroxyprogesterone acetate at 12 months, and the most common reasons for discontinuation were irregular uterine bleeding and weight gain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade Federal de São Paulo Escola Paulista de Medicina Department of Obstetrics São PauloSP Brazil Department of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
ORCID-Profile: Giani Silvana Schwengber Cezimbra, Edward Araujo Júnior, Cristina Aparecida Falbo Guazzelli
Zitieren
APA
Cezimbra, G. S. S., Araujo Júnior, E., & Guazzelli, C. A. F. (2025). Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate. Revista Brasileira de Ginecologia e Obstetrícia. https://doi.org/10.61622/rbgo/2025rbgo9
Vancouver
Cezimbra GSS, Araujo Júnior E, Guazzelli CAF. Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate. Revista Brasileira de Ginecologia e Obstetrícia. 2025. doi:10.61622/rbgo/2025rbgo9
BibTeX
@article{Cezimbra2025,
author = {Cezimbra, Giani Silvana Schwengber and Araujo Júnior, Edward and Guazzelli, Cristina Aparecida Falbo},
title = {Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate},
journal = {Revista Brasileira de Ginecologia e Obstetrícia},
year = {2025},
doi = {10.61622/rbgo/2025rbgo9}
}
EUVIMED